Routine histopathologic characteristics can predict oncotype dx tm recurrence score in subsets of breast cancer patients

Cancer Investigation

Volumn 31, Issue 9, 2013, Pages 604-606

  Mattes, Malcolm D ^a   Mann, Justin M ^b   Ashamalla, Hani ^a   Tejwani, Ajay ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Breast cancers; Oncotype DX; PR expression

Indexed keywords

ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GRADING; CANCER RECURRENCE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR VOLUME;

ANALYSIS OF VARIANCE; BIOPSY; BREAST NEOPLASMS; DECISION SUPPORT TECHNIQUES; FEMALE; GENETIC TESTING; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; NEOPLASM GRADING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84887228047     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357907.2013.849725     Document Type: Article

References (13)

1. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, WalkerMG, Watson D, Park T, Hiller W, Fisher ER,Wickerham DL, Bryant J,WolmarkN. Amultigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004;351:2817-2826.
2. Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, Cronin M, Baehner FL, Watson D, Bryant J, Costantino JP, Geyer CE Jr, Wickerham DL, Wolmark N. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptorpositive breast cancer. J Clin Oncol 2006;24:3726-3734.
3. National Comprehensive Cancer Network-R (NCCN). Practice Guidelines in Oncology: Breast Cancer, Version
4. Fort Washington, PA: National Comprehensive Cancer Network, Inc, 2012. www. nccn. org
5. College of AmericanPathologists. Protocol for theExaminationof Specimens From PatientsWith Invasive Carcinoma of the Breast. Version InvasiveBreast 3. 1. 0. 0. Northfield, IL: College of American Pathologist. www. cap. org.
6. Auerbach J, Kim M, Fineberg S. Can features evaluated in the routine pathologic assessment of lymph node-negative estrogen receptor-positive stage I or II invasive breast cancer be used to predict the Oncotype DX recurrence score? Arch Pathol LabMed 2010;134:1697-1701.
7. Allison KH, Kandalaft PL, Sitlani CM, Dintzis SM, Gown AM. Routine pathologic parameters can predict Oncotype DX recurrence scores in subsets of ER positive patients: who does not always need testing? Breast Cancer Res Treat 2012;131:413-424.
8. Flanagan MB, Dabbs DJ, Brufsky AM, Beriwal S, Bhargava R. Histopathologic variables predict Oncotype DX recurrence score. Mod Pathol 2008;21:1255-1261.
9. Tang P, Wang J, Hicks DG, Wang X, Schiffhauer L, McMahon L, Yang Q, Shayne M, Huston A, Skinner KA, Griggs J, Lyman G. A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancer. Cancer Invest 2010;28:978-982.
10. Cuzick J, Dowsett M, Wale C, Salter J, Quinn E, Zabaglo L, Howell A, Buzdar A, Forbes JF. Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer. J Clin Oncol 2011;29:4273-4278.
11. Clark BZ, Dabbs DJ, Cooper, KL, Bhargava R. Impact of Progesterone Receptor Semiquantitative Immunohistochemical Result on Oncotype DX Recurrence score: A Quality Assurance Study of 1074 Cases. Appl Immunohistochem Mol Morphol 2013;21:287-291.
12. Geradts J, Bean SM, Bentley RC, Barry WT. The oncotype DX recurrence score is correlated with a composite index including routinely reported pathobiologic features. Cancer Invest 2010;28:969-977.
13. Klein ME, Dabbs DJ, Shuai Y, Brufsky AM, Jankowitz R, Puhalla SL, Bhargava R. Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis. Mod Pathol 2013;26:658-664.